{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T13:39:15Z","timestamp":1781617155936,"version":"3.54.5"},"reference-count":16,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["agsjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J American Geriatrics Society"],"published-print":{"date-parts":[[2026,4]]},"abstract":"Summary<\/jats:title>\n \n \n \n \n Key points\n \n \n The \u201cbest\u201d method of estimating glomerular filtration rate or creatinine clearance for calculation of medication doses in older adults remains elusive.<\/jats:p>\n <\/jats:list-item>\n \n Inclusion of cystatin C may enhance precision and lower bias of glomerular filtration rate estimates compared to serum creatinine alone.<\/jats:p>\n <\/jats:list-item>\n \n Clinicians may wish to use multiple equations to estimate a patient's renal function and calculate medication doses while considering the potential for adverse effects or therapeutic failure if the dose is rounded up or down based on the patient's estimated kidney function<\/jats:p>\n <\/jats:list-item>\n <\/jats:list>\n <\/jats:p>\n <\/jats:list-item>\n \n \n Why does this paper matter?\n \n \n In the absence of sufficient evidence to support or refute NKF recommendations, older adults are at risk of error estimating renal impairment and over\u2010 or under\u2010dosing medications eliminated by the kidneys.<\/jats:p>\n <\/jats:list-item>\n <\/jats:list>\n <\/jats:p>\n <\/jats:list-item>\n <\/jats:list>\n <\/jats:p>","DOI":"10.1111\/jgs.70280","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T10:24:11Z","timestamp":1767608651000},"page":"1213-1217","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The\n NKF<\/scp>\n Has Spoken: Now, What's a Clinician to Do?"],"prefix":"10.1111","volume":"74","author":[{"given":"Barbara J.","family":"Zarowitz","sequence":"first","affiliation":[{"name":"The Peter Lamy Center on Drug Therapy and Aging University of Maryland School of Pharmacy Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Van","sequence":"additional","affiliation":[{"name":"The Peter Lamy Center on Drug Therapy and Aging University of Maryland School of Pharmacy Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd P.","family":"Semla","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine\/Geriatrics & Department of Psychiatry and Behavioral Science Northwestern University Feinberg School of Medicine Evanston Illinois USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01030120"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.49111"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1159\/000180580"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13643"},{"issue":"4","key":"e_1_2_8_6_1","first-page":"S117","article-title":"KDIGO 2024 Clinical Practice Guidelines for the Evaluation and Management of Chronic Kidney Disease","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","journal-title":"Kid Internal"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxae317"},{"key":"e_1_2_8_8_1","unstructured":"Center for Drug Evaluation and Research US Food and Drug Administration \u201cPharmacokinetics in Patients With Impaired Renal Function \u2013 Study Design Data Analysis and Impact on Dosing (Guidance for Industry) \u201d(2024) https:\/\/www.fda.gov\/media\/78573\/download."},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1282"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004070549"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.70000"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2023.105107"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15132"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1114248"},{"key":"e_1_2_8_16_1","unstructured":"Centers for Medicare & Medicaid Services \u201cBilling and Coding: Cystatin C Measurement \u201d(2024) https:\/\/www.cms.gov\/medicare\u2010coverage\u2010database\/view\/article.aspx?articleid=56988&ver=16&keyword=cystatin%20c&keywordType=starts&areaId=all&docType=NCA CAL NCD MEDCAC TA MCD 6 3 5 1 F P&contractOption=all&sortBy=relevance&bc=1."},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2020.04.010"}],"container-title":["Journal of the American Geriatrics Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jgs.70280","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jgs.70280","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jgs.70280","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T04:22:47Z","timestamp":1776226967000},"score":1,"resource":{"primary":{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/10.1111\/jgs.70280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1111\/jgs.70280"],"URL":"https:\/\/doi.org\/10.1111\/jgs.70280","archive":["Portico"],"relation":{},"ISSN":["0002-8614","1532-5415"],"issn-type":[{"value":"0002-8614","type":"print"},{"value":"1532-5415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"2025-11-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}